Background-Marfan syndrome (MFS) is a heritable disorder of connective tissue, affecting principally skeletal, ocular, and cardiovascular systems. The most life-threatening manifestations are aortic aneurysm and dissection. We investigated changes in the proteome of aortic media in patients with and without MFS to gain insight into molecular mechanisms leading to aortic dilatation. Methods and Results-Aortic samples were collected from 46 patients. Twenty-two patients suffered from MFS, 9 patients had bicuspid aortic valve, and 15 patients without connective tissue disorder served as controls. Aortic media was isolated and its proteome was analyzed in 12 patients with the use of 2-dimensional difference gel electrophoresis and mass spectrometry. We found higher amounts of filamin A C-terminal fragment, calponin 1, vinculin, microfibrilassociated glycoprotein 4, and myosin-10 heavy chain in aortic media of MFS aneurysm samples than in controls. Regulation of filamin A C-terminal fragmentation was validated in all patient samples by immunoblotting. Cleavage of filamin A and the calpain substrate spectrin was increased in the MFS and bicuspid aortic valve groups. Extent of cleavage correlated positively with calpain 2 expression and negatively with the expression of its endogenous inhibitor calpastatin. Conclusions-Our observation demonstrates for the first time upregulation of the C-terminal fragment of filamin A in dilated aortic media of MFS and bicuspid aortic valve patients. In addition, our results present evidence that the cleavage of filamin A is highly likely the result of the protease calpain. Increased calpain activity might explain, at least in part, histological alterations in dilated aorta. (Circulation. 2009;120:983-991.)
M arfan syndrome (MFS) is a disorder of connective tissue caused by mutations in the fibrillin-1 gene (FBN-1) that may lead to abnormal regulation of transforming growth factor-␤ (TGF-␤) signaling. 1 Clinical manifestation implies principally the cardiovascular, skeletal, and ocular systems, and other systems such as skin, lung, and dura may also be affected. Cardiovascular defects involve dilatation of the ascending aortic root leading to aortic aneurysm and dissection, which are the main cause of morbidity and mortality in MFS, and mitral valve prolapse with or without regurgitation. 2 
Clinical Perspective on p 991
Molecular mechanisms of aneurysm formation and its treatment are the subject of intensive research. Three key proteins seem to directly contribute to aneurysm formation. First, defective fibrillin-1 is thought to alter targeting and sequestration of TGF-␤, leading to increased TGF-␤ activity. 1 Blocking TGF-␤ activity with antagonists such as TGF-␤-neutralizing antibodies prevents aneurysm formation in a mouse model of MFS. 3 Second, angiotensin II (Ang II) is upregulated in MFS. 4 Treatment of patients with Ang II type 1 (AT 1 ) receptor (AT 1 R) blocker or angiotensin-converting enzyme (ACE) inhibitors reduces progression of aortic dilation in MFS. 3, [5] [6] [7] Attenuation of aortic remodeling by lowering Ang II levels can be mediated by TGF-␤-dependent and -independent mechanisms. 8 Third, proteases play a pivotal role in the pathology of aortic dilatation. We have profiled the activity of matrix metalloproteinases (MMPs) in MFS aortic aneurysms. 9 Studies in the MFS mouse model revealed the upregulation of MMP-2 and -9. 10 Calpains are another class of proteases not yet associated with MFS aortic aneurysm. Calpains are calcium-dependent cysteine proteases that cleave many intracellular signaling and structural proteins. The 2 major isoforms, calpain 1 and calpain 2, are ubiquitously expressed and differ in their tertiary structure and Ca 2ϩ requirements. 11 Activation of calpain is regulated by its endogenous inhibitor calpastatin, intracellular localization of the protease, and local Ca 2ϩ concentrations. Recent studies have implicated the calpain/ calpastatin system in Ang II-induced cardiovascular remodeling. 12 Evidence exists that Ang II induces calpain expression and activity and further leads to upregulation of MMP-2. 12, 13 Because elevated Ang II levels and increased MMP-2 activity are elements in the initiation and progression of aortic aneurysms, the calpain/calpastatin system might play an important role in MFS aortic remodeling and dilatation.
The aim of the present study was to investigate differences in the proteome of aortic media in patients with and without MFS to gain new insights into the pathological mechanisms of aortic dilatation. Increased filamin A fragmentation in dilated aortic media of MFS and bicuspid aortic valve (BAV) patients led us to further investigate the proteolytic calpain/ calpastatin system.
Methods

Source of Tissue
Aneurysm tissue from ascending aorta was obtained from 22 MFS patients at the time of aortic root replacement and from 9 BAV patients. Ascending aorta of 15 non-MFS and non-BAV patients without aortic dilation served as a control group. Heart transplant patients and patients suffering from tricuspid aortic valve stenosis, undergoing elective aortic valve replacement, were primarily included. MFS diagnosis was based on Ghent criteria and in 5 patients was confirmed by genetic mutation analysis (for results, see the online-only Data Supplement). All MFS patients had a tricuspid aortic valve. Written informed consent was obtained from all patients, according to local ethics committee approval of the University Hospital of Bern and the University of Pennsylvania.
Aortic tissue was dissected into adventitia, media, and intima. From each tissue, 1 section was immediately snap-frozen in liquid nitrogen and stored at Ϫ70°C until protein analysis. Another section was fixed with 4% paraformaldehyde in phosphate-buffered saline for histological examination.
Histology
Fixed tissue was dehydrated in an automatic tissue processor, embedded in paraffin, and cut into 4-m sections for histochemical evaluation. Sections were stained with Verhoeff-van Gieson protocol for evaluation of tissue separation.
Two-Dimensional Differential Gel Electrophoresis
Samples from 12 patients were used for proteomic analysis. For high resolution of proteins and minimal gel-to-gel variation, 2-dimensional differential gel electrophoresis (2D-DIGE) was performed. Therefore, proteins from aortic aneurysms were labeled with different fluorophores than nonaneurysm proteins (Cy3 and Cy5). For details, please refer to the online-only Data Supplement.
Image Analysis
Labeled proteins were visualized with the use of a Typhoon 9400 imager (GE Healthcare). Spot matching, quantification, and statistical analyses were performed with the use of Proteomweaver software (Definiens AG, Munich, Germany). Scanned images were uploaded into the software, and automated spot detection and quantification were performed. The software identified spot candidates by detecting local maxima in the gray-scale gel image, and the outline of those was calculated with the use of a downhill gradient flood-filling algorithm. The same spots in different gels were matched with the use of a pattern-matching algorithm that depends on spot features and the geometry and features of its neighbors. The spot quantification calculated the spot volume with the use of the integral of a Gaussian approximation corrected by a factor that depends on the local background level. Normalized protein spots in the Cy3 and Cy5 images were compared with the internal standard (Cy2) to generate ratios of relative amounts. Protein spots were considered to be significantly differentially regulated when the t test value was PϽ0.05 and the regulation factor Ͼ2.
Mass Spectrometry
For identification of differentially regulated protein spots, spot candidates were picked from the gel and trypsin digested. Eluted peptides were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and liquid chromatography mass spectrometry. For details, please refer to the online-only Data Supplement.
Immunoblotting
Protein cleavage and relative abundance of differentially expressed proteins were examined with the use of Western blot technology. Briefly, 5 g of aortic media extracted in DIGE buffer was loaded onto a 10% polyacrylamide/sodium dodecyl sulfate gel and subjected to separation by electrophoresis. Proteins were electroblotted onto polyvinylidene fluoride membrane (Hybond, GE Healthcare). Antibodies against the C-terminus of filamin A, calpastatin, ␣-2 spectrin, ␤-actin (Santa Cruz Biotechnology, Santa Cruz, Calif), and calpain 2 (Cell Signaling Technology, Danvers, Mass) were used. Positive immunoreactivity was detected with chemiluminescence substrate (ECL detection reagent, GE Healthcare) and exposure of the blots to film (Hyperfilm, GE Healthcare). After development, films were digitized, and quantitative densitometric image analysis was performed (ImageJ 1.39C; http://rsbweb.nih.gov/ij/). Protein cleavage was assessed as the amount of cleavage fragment relative to the amount of full-length protein. Cleavage of ␣-2 spectrin was used as a measure for calpain activity. 14
Statistical Analysis
For statistical comparisons, parametric (t test, Pearson correlation coefficient) and nonparametric (Mann-Whitney test, Spearman correlation coefficient) tests were used. If Ͼ2 groups were compared, ANOVA followed by Bonferroni post hoc test for multiple comparisons and Kruskal-Wallis followed by Dunn post hoc test for multiple comparisons were applied. Pearson 2 test was used for categorical data. Distributional normality was tested with the use of D'Agostino and Pearson omnibus normality test. Values are given as meanϮSEM.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Patient Characteristics
There were no differences in sex (controls, 67Ϯ13% male; MFS, 83Ϯ8% male; BAV, 67Ϯ17% male; Pϭ0.50). Mean age differed between MFS and control groups (controls, 60Ϯ3 years; MFS, 38Ϯ4 years; PϽ0.001) but not between BAV and control groups (BAV, 57Ϯ3 years; Pϭ0.70). Mean aortic diameters were similar in MFS and BAV groups (MFS, 4.99Ϯ0.12 cm; BAV, 4.84Ϯ0.19 cm; Pϭ0.29) and different from controls (controls, Ͻ3.5 cm; PϽ0.001). Arterial hypertension was present in 14 patients but was independent of MFS status (controls, 27%; MFS, 36%; BAV, 22%; Pϭ0.69). Most patients with hypertension received AT 1 R blockers or ACE inhibitors (controls, 27%; MFS, 14%; BAV, 11%; Pϭ0.51). Treatment with ␤-blockers was significantly higher in the MFS group (controls, 33%; MFS, 73%; BAV, 33%; Pϭ0.03).
Histology
Histology and quality of separation technique were investigated in aortic samples for proteomic analysis with the use of van Gieson elastic stain ( Figure 1 ). The tissue separation technology revealed well-dissected media in control, MFS, and BAV samples. Fragmentation of elastic fibers was present in media of MFS patients and to a lesser extent in BAV patients.
Differentially Expressed Proteins in MFS Aortic Media
Protein expressions of aortic media from 6 randomly selected MFS aneurysm patients and 6 randomly selected controls were compared with the use of 2D-DIGE. Each gel contained the aortic media proteome of MFS patients, control patients, and an internal standard. Between 997 and 1247 protein spots were resolved according to the spot detection tool of the image analysis software. Six spots were found to be significantly upregulated in MFS aortic media, whereas 20 protein spots were downregulated Ͼ2-fold (PϽ0.05) ( Figure 2 ). From the colloidal Coomassie-stained gels, 17 spots could be picked and subjected to mass spectrometry. The Table lists the identified protein spots as outlined in Figure 2 . Details of mass spectrometric identification are summarized in Table I of the online-only Data Supplement. Upregulated proteins were myosin-10 heavy chain, vinculin, filamin A, microfibrilassociated glycoprotein 4 (MFAP 4), and calponin 1. Downregulated proteins were vitamin-D binding protein, fructosebisphosphate aldolase C, apolipoprotein A-I, serum amyloid P, transgelin, and hemoglobin ␤ and ␣ chains. Comparison of the molecular weight of separated proteins with theoretical values and analysis of the sequence coverage achieved by mass spectrometry revealed that filamin A was not upregulated as an entire protein but as C-terminal fragment. Proteolysis was also observed for calponin 1. The entire protein with a molecular weight of 33 kDa was upregulated as well as its fragment of 20 kDa. The occurrence of fragmentation of these 2 proteins attracted our interest in relation to proteolytic activity of MFS media from aortic aneurysms.
Filamin A C-Terminal Fragment
We confirmed the upregulation of filamin A C-terminal fragment from proteomic analysis in the entire study population using Western blot. Use of a specific antibody against the C-terminus of filamin A revealed bands at 280 kDa, representing the full-length protein, and bands at 90 and 110 kDa, representing the fragments detected in our proteomic analysis ( Figure 3 ). Comparison of the ratio of cleavage products to substrate revealed a significant upregulation of filamin A cleavage in the MFS and BAV groups compared with controls (controls, 2.04Ϯ0.21; MFS, 2.64Ϯ0.17; Pϭ0.02 from controls; BAV, 3.04Ϯ0.21; Pϭ0.004 from controls).
Calpain 2
Calpain 2 activity was assessed by measuring the cleavage fragments of ␣-2 spectrin at 145/150 kDa. 14 We found a significantly upregulated cleavage of ␣-2 spectrin in aneurysmal aortic media compared with controls (controls, 0.70Ϯ0.08; MFS, 1.05Ϯ0.09; Pϭ0.007 from controls; BAV, 1.15Ϯ0.10; Pϭ0.006 from controls). Subgroup analysis in all patients revealed that hypertension did not result in elevated spectrin cleavage (see online-only Data Supplement). Furthermore, there was a strong correlation between filamin A and ␣-2 spectrin cleavage (rϭ0.92, PϽ0.001; nϭ46), confirming that calpain 2 is involved in filamin A cleavage (Figure 4 ). Quantification of calpain 2 expression and its inhibitor calpastatin revealed a positive correlation of calpain 2 with filamin A (rϭ0.33, Pϭ0.03; nϭ46) and spectrin cleavage (rϭ0.41, Pϭ0.005; nϭ46) and a negative correlation of calpastatin with filamin A (rϭϪ0.31, Pϭ0.04; nϭ46) and spectrin cleavage (rϭϪ0.43, Pϭ0.003; nϭ46) ( Figure  5 ). Interestingly, the ratio of calpain 2 and its inhibitor calpastatin highly correlated with filamin A (rϭ0.47, PϽ0.001; nϭ46) as well as with spectrin cleavage (rϭ0.60, PϽ0.001; nϭ46).
Discussion
Thoracic aortic aneurysms and aortic dissection are the major cause of premature death in MFS. 2 Until recently, the common treatment methods for MFS aneurysms were lifelong medication with ␤-blockers and repair of dilated aorta. 7 New insights into molecular mechanisms of aortic dilatation in MFS have revealed that TGF-␤, Ang II, and MMPs are upregulated, thus leading to new treatment options. Antagonism of TGF-␤ with neutralizing antibodies, blockage of AT 1 R with losartan, and inhibition of ACE by perindopril and of MMP-2 and -9 by doxycycline showed attenuation of aortic root dilation and reduced TGF-␤ activity in aortic media of mice and humans. 3, 6, 15 In the present study, we analyzed aortic media to explore new molecular alterations associated with thoracic aortic aneurysms in MFS. We used 2D-DIGE to detect differences in protein abundance and mass spectrometry for subsequent protein identification. To minimize contamination of the aortic proteome by blood cells or plasma proteins and to investigate the aortic tunica that is primarily involved in the pathogenesis of aneurysm formation, we dissected the aorta and only analyzed aortic media for differential regulation.
Most interesting was the finding that the filamin A C-terminal fragmentation is upregulated in aortic media of MFS and BAV patients. Intact filamin A is a high-molecularweight protein that cross-links and organizes actin filaments into parallel arrays of 3-dimensional webs. In addition, filamin A-interacting proteins such as TGF-␤ receptor-activated Smads, which bind to the C-terminus, are important signaling molecules. 16 Mutations in filamin A are responsible for familial cardiac valvular dystrophy and aortic aneurysms in periventricular nodular heterotopia. 17 Furthermore, filamin gene expression in mitral valves in a mouse model of MFS is significantly increased in homozygote animals. 18 The C-terminal region of filamin A, which we found to be upregulated in MFS and BAV aneurysm media, reveals functions other than the intact protein. The fragment itself has the capacity to translocate to the nucleus together with the androgen receptor, resulting in the repression of androgen receptor transcriptional activity. 19 Moreover, filamin A C-terminal fragments as well as the spectrin fragment have recently been proposed as parts of biomarker panels. The filamin A C-terminal fragment was secreted from aorta that underwent arterial wall remodeling. 20 Increased spectrin fragments were found in cerebrospinal fluid of patients with mild central nervous system injury. 21 Filamin A is cleaved by the proteases calpain, caspase, and granzyme B. 22, 23 Evaluating caspase 3 and granzyme B activity in a subset of patients showed no difference between normal aorta and MFS aneurysm (data not shown), whereas calpain did. Calpain activity was assessed by measuring cleavage of its endogenous substrate spectrin. We found increased cleavage of spectrin in MFS and BAV aortic aneurysm that highly correlated with the increase of filamin A cleavage. Furthermore, increase of spectrin and filamin A proteolysis correlated with increasing calpain expression and decreasing expression of its inhibitor calpastatin. Because of Table and Table I in the online-only Data Supplement. Three-dimensional images emphasize the differences in protein quantity in the example of the filamin A isoforms.
the high correlation between spectrin and filamin A cleavage in the absence of increased activity of caspase 3 and granzyme B, we conclude that both proteolytic digestions result from the action of calpain, which is attributable to higher protease expression as well as lowered expression of its inhibitor.
Increased activity of calpain is known from different pathological states such as from cardiovascular remodeling after Ang II-induced hypertension and from aging. 12, 13 Recently, Letavernier et al 12 demonstrated that infusion of Ang II in mice resulted in increased calpain and decreased calpastatin expression. The group further showed that overexpression of the inhibitor calpastatin decreased MMP-2 and -9 activity and attenuated Ang II-induced vascular remodeling with focus on hypertrophy, perivascular inflammation, and tissue fibrosis. 12 Interestingly, administration of losartan restored basal calpain levels. Losartan therefore offers a pharmacological approach to reduce excessive activity of calpain. Furthermore, TGF-␤-induced apoptosis in rat hepatocytes was greatly attenuated by inhibiting calpain 1 and more efficiently by inhibiting calpain 2. 24 Thus, calpain inhibition might potentially also attenuate TGF-␤ activity.
Ang II mRNA expression in MFS aortic aneurysm and Ang II concentrations measured by enzyme-linked immunosorbent assay were elevated compared with controls. 4 Confirming this, antagonism of Ang II with the AT 1 R blocker losartan or ACE inhibitors blunted aortic dilatation and decreased TGF-␤ activation. 3, 4, 6 Ang II also stimulated Smad 2-dependent signaling and fibrosis in vascular smooth muscle cells (VSMCs) in a TGF-␤independent manner, an effect prevented by selective AT 1 R blockade. 8 Thus, we speculate that calpain plays a role in TGF-␤dependent and -independent Smad activation in the setting of increased Ang II concentrations.
Calpain can be activated in VSMCs by mechanical stress. Mechanical stress led to an increase in VSMC Ang II by elevation of ACE expression, and it increased calpain activation, seeming to counteract VSMC apoptosis by degradation of p53. 25, 26 We observed a correlation between aortic diameter and ␣-2 spectrin cleavage (see the online-only Data Supplement). Because mechanical stress increases with aortic diameter, elevated calpain activity may be the result of augmented wall stress.
Nearly 50% of patients with BAV develop a dilatation of the ascending aorta or aortic sinus. 27 The mechanism remains controversial; genetic predisposition seems to play an important role in the initiation of aortic dilation rather than aberrant postvalvular hemodynamics. 28 Histological changes in dilated aortic media share similarities with those seen in MFS, including increased VSMC apoptosis, cystic medial necrosis, elastin fragmentation, and upregulation of MMP-2. 29, 30 Histological parallels, together with presumed genetic defects of the extracellular matrix, lead us to assume that calpain is also activated in BAV. Indeed, our results present evidence that filamin A and spectrin cleavage increase to a similar extent in MFS compared with controls. Therefore, increased calpain activity is a feature of both syndromes and suggests that BAV-associated aortic dilation is pathogenetically closer to that in MFS than assumed previously. To analyze whether the same holds true for conditions such as age-and hypertensionassociated ectasia with tricuspid valves, we examined calpain activity in this additional group and observed further increased spectrin cleavage (see the online-only Data Supplement). Because hypertension is another cause of wall stress, we achieved further evidence that wall stress may increase calpain activity by possible elevation of tissue Ang II and may further lead to abnormal vascular remodeling.
Using 2D-DIGE, we observed upregulation of 4 additional proteins in MFS aneurysm. The actin-binding molecules vinculin and calponin were more highly expressed in the MFS group compared with controls. Vinculin is a membranecytoskeletal protein stabilizing focal adhesions and suppressing cell migration. 31 Upregulation of the protein in smooth muscle cells was observed on mechanical stretch. 32 Calponins are upregulated in mechanically stretched VSMCs, partially by the action of Rho-associated kinase. 33 Calponin 1 might therefore be involved in regulation and modulation of smooth muscle cell contraction and act as a signal for cell differentiation. 34 The MFS aneurysm is associated with increased levels of TGF-␤, and, interestingly, stimulation of VSMCs with TGF-␤ increases calponin 1. 35 Therefore, upregulation of calponin 1 could be an indirect marker of increased TGF-␤ signaling. We observed 2 different types of calponin-1, accounting for the full-length protein (33 kDa) and a fragment thereof (20 kDa). In analogy to filamin A, calponins can be cleaved by calpain. 36 Another observation was the upregulation of MFAP 4 in aortic dilation. MFAP 4 is a 29-kDa elastin-binding protein and plays a role in elastogenesis. 37 Furthermore, MFAP 4 has high sequence homology to the aortic aneurysm-associated protein-40, which has been found in human abdominal aortic aneurysm. 38 Although not much is known about MFAP 4, there are indications that it might play an important role in aneurysm formation.
Furthermore, we found upregulation of cellular myosin-10. It has been reported that myosin-10 heavy chain creates links between microtubules and the actin cytoskeleton as well as between integrins and the cytoskeleton. 39 Myosin-10 heavy chain overexpression is associated with an increased number of filopodia, which are important for cell migration. It is difficult to attribute a function to myosin-10 heavy chain in the context of MFS. Because aneurysm formation is in part an inflammatory process, it possibly leads to increased migration of VSMCs.
Limitations of the Study
First, the proteome of aortic media consists of an enormous number of different proteins, and 2 subsequent protein separation techniques are not feasible to separate all of them in a satisfactory manner. Additionally, the dynamic range of protein expression spans 7 or 8 orders of magnitude. Furthermore, proteins within a given proteome are structurally diverse and present various physicochemical characteristics. Some of these proteins are alkaline or hydrophobic, are of poor solubility, or have different staining characteristics. Therefore, the present study in the proteome of aortic aneurysm in MFS revealed interesting protein expression changes, but it could never detect them all. Second, results of proteomic studies have to be validated with an alternative method as we did using Western blot technology. Because our interest was the filamin A C-terminal fragment and its proteolysis, we did not validate the other proteins discussed here. Third, enzyme-linked immunosorbent assay and zymography are 2 additional methods of confirming calpain upregulation. Because samples of human aortic media are rare and quantity is limited, further calpain confirmation could not be performed. Fourth, control subjects were in general older than MFS patients, and calpain is known to be upregulated with aging. 13 However, in the present study, calpain was upregulated in younger MFS patients, and we therefore did not consider this finding to be biased by differences in age.
Conclusions
Using proteomic techniques, we identified upregulation of the filamin A C-terminal fragment in aortic media of MFS patients suffering from aneurysm of the ascending aorta. We further observed indicators of increased TGF-␤ signaling and enhanced mechanical stress in MFS aortic aneurysm. Elevated filamin A cleavage was a result of higher calpain activity in MFS as well as in BAV patients. Increased filamin A fragmentation and elevated calpain activity have been shown to play a role in Ang II-induced vascular remodeling. Increased calpain activity in aortic aneurysms may be the result of increased aortic wall stress. Pharmacological inhibition of calpain might prevent uncontrolled proteolysis and further signaling. Because the development of calpain inhibitors has been complicated, AT 1 R blockers are the preferred approach for normalizing calpain activity in aortic media of MFS and BAV patients. Further research in the field of serum filamin A and spectrin fragmentation in MFS and BAV patients might present evidence for them to serve as potential serum biomarkers.
